NCT02168231

Brief Summary

Incisional hernia is the most frequently seen long term complication in surgery causing much morbidity and even mortality in patients. Despite studies on the optimal closing technique for laparotomies, the risk for incisional hernia after midline incision remains about 5-20%. It has been established that implementing a mesh reduces recurrence of the incisional hernia but still the results of repair are often disappointing. Incisional hernias can become increasingly complex due to complicated abdominal wall defects caused by a disturbed anatomy, fistulas, burst abdomen, wound and mesh infections. In these cases it is not save to repair the incisional hernia by means of a synthetic mesh and other augmentation tools need to be implemented. In the recent years the use of biological meshes has been gaining popularity. Recent reports of the use of collagen-based prosthesis have suggested that they support new vessel growth, do not excite a significant foreign body reaction, form fewer adhesions, are well incorporated into host tissues with minimal wound contraction, and can be used in grossly contaminated wounds with fewer infective complications. Biologic meshes are harvested from a source tissue and processed for medical use but they vary widely in their processing methods. They include tissues of human or animal origins, both chemically cross-linked and non cross-linked processes, and submucosal, pericardial, or dermal tissue sources. Current studies investigating the effectiveness of these meshes are small and have short periods of follow-up. These shortcomings can be explained to high cost of the meshes and unclear indication when to use a biological mesh. The aim of this study is to investigate the short and long term effects of the Strattice biological mesh. The investigators will also inquire why a biologic mesh was used and what the direct and indirect costs were.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 20, 2014

Completed
2.6 years until next milestone

Study Start

First participant enrolled

February 1, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

August 7, 2018

Status Verified

August 1, 2018

Enrollment Period

1.9 years

First QC Date

June 12, 2014

Last Update Submit

August 4, 2018

Conditions

Keywords

Complex abdominal wall herniaBiologic meshStrattice

Outcome Measures

Primary Outcomes (3)

  • Incisional hernia recurrence

    This parameter will be assessed by taking a history of the patient, and performing physical examination.

    At one year after initial operation

  • Postoperative complications

    All postoperative complications and their treatment will be registered.

    Postoperatively, until one year after initial operation

  • Survival

    Any decease postoperatively

    Postoperatively; until three years after initial operation

Secondary Outcomes (7)

  • EHS incisional hernia classification

    Perioperatively (noted just before or just after operation)

  • Mesh explantations

    Postoperatively; until three years after initial operation

  • Additional "abdominal wall repair" operations

    Postoperatively; until three years after initial operation

  • Indication of Strattice usage

    Perioperatively (noted just before or just after operation)

  • Quality of Life (questionnaire-based)

    Postoperatively; measured at one, two and three years after initial operation

  • +2 more secondary outcomes

Study Arms (1)

Complex abdominal wall repair Strattice

Complex abdominal wall repair Strattice

Procedure: Complex abdominal wall repair Strattice

Interventions

Not applicable (cross-sectional data from a cohort selected after initial complex abdominal wall surgery with Strattice)

Also known as: Strattice, Porcine accelular dermal matrix, Non-cross-linked biologic mesh
Complex abdominal wall repair Strattice

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients operated by members of the ROKI group (Arbeitsgruppe für Rekonstruktion komplexer Inzisionaler Hernien); i.e. a group of German hernia surgeons using Strattice for complex abdominal wall surgery. This group of surgeons is willing to share their patient cases with the investigators to achieve more knowledge on this delicate topic.

You may qualify if:

  • Age of 18 years or older
  • Signed informed consent
  • Abdominal wall repair

You may not qualify if:

  • Age under 18 years
  • No signed informed consent
  • Other operation than abdominal wall repair
  • Other mesh than Strattice mesh

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Trauma Hospital Berlin

Berlin, Germany

Location

Johann Wolfgang Goethe-University

Frankfurt am Main, Germany

Location

Diakoniekrankenhaus Friederikenstiftung

Hanover, Germany

Location

Agatharied Hospital

Hausham, Germany

Location

Klinikum rechts der Isar, Technical University of Munich

München, Germany

Location

St. Josefs-Hospital Wiesbaden

Wiesbaden, Germany

Location

Related Publications (1)

  • Kaufmann R, Isemer FE, Strey CW, Jeekel J, Lange JF, Woeste G. Non-cross-linked biological mesh in complex abdominal wall hernia: a cohort study. Langenbecks Arch Surg. 2020 May;405(3):345-352. doi: 10.1007/s00423-020-01881-4. Epub 2020 Apr 22.

MeSH Terms

Conditions

Hernia, Abdominal

Interventions

strattice

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Ruth Kaufmann, MD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD fellow

Study Record Dates

First Submitted

June 12, 2014

First Posted

June 20, 2014

Study Start

February 1, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

August 7, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations